wp-fail2ban domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6170wptelegram-pro domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6170wptelegram domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6170
NewLimit, a biotech startup co-founded by Coinbase CEO Brian Armstrong, raised $435 million in Series C funding to move its first age-reprogramming drug towards human trials. The round was led by Founders Fund, with new investors joining. The company focuses on epigenetic reprogramming to treat age-related diseases and aims to bring longevity medicine to human trials next year. Armstrong’s involvement in the biotech sector expands beyond his cryptocurrency business.
Leave a Reply